CG Oncology, Inc.

NASDAQ: CGON
Share price (12/23/24): $28.13
Market cap (12/23/24): $1.902 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement with pricing info

Initial registration of new securities – amended

Initial registration of new securities

Draft registration statement

Registration of securities for employees

Ownership Filter

Vanguard Group Inc

News Filter

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Reports Third Quarter 2024 Financial Results and Provides Business Updates

Reports Second Quarter 2024 Financial Results and Provides Business Updates

To Present Positive Final Results From Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination With Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting

Reports First Quarter 2024 Financial Results and Provides Business Updates

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

SEC STAFF LETTER

Notice of effectiveness

Correspondence with the SEC